Halozyme Therapeutics Inc (HALO)

[stockrafter]

Couple of things.

1) The new Merck formulation is related to the Altegon deal. Do a search on Merck, Altegon.

And this is interesting on their site....Hyaluronidase : A new way to be excluded from drug price negotiations under IRA

http://www.alteogen.com/en/ir_1/?uid=1787&mod=document&pageid=1

2) Not sure West would be interested in Halo, since they have their own line of injectors, but who knows....

3) Best guess, Elektrofi is working with Halozyme, with several top management connection, and info in patent, certainly a possibility, IMO.

https://www.elektrofi.com

https://www.freepatentsonline.com/WO2023212721A1.html

4) No mention on this loss, but good riddance....What an over priced worthless drug.

"Please be advised that as of October 19, 2023, Antares Pharma, Inc. (a wholly owned subsidiary of Halozyme Therapeutics, Inc.) is no longer marketing Nocdurna, due to the termination of its license agreement with Ferring Pharmaceuticals, the manufacturer of Nocdurna. Nocdurna will remain available at local pharmacies until stock inventory is exhausted."